Become a Partner
Shaping the Future of Cancer Diagnostics Together
QuantView GmbH is revolutionizing medical imaging through parahydrogen-induced hyperpolarization (PHIP)—a groundbreaking technology that enhances MRI contrast, enabling faster, more precise cancer detection. As a spin-off from Kiel University, we bring cutting-edge research to the forefront of real-world clinical applications.
We invite strategic partners and investors to join us on this transformative journey. Whether you are an MRI/MRT company, an AI-driven imaging innovator, a venture capital firm, or a family office, your expertise and support can accelerate our mission to redefine cancer diagnostics.
Why Partner with Us?
- Invest in Disruptive Innovation – Back a high-potential startup at the intersection of quantum physics, chemistry, and medical imaging.
- Strategic Industry Impact – Shape the next generation of contrast agents for MRI/MRT applications.
- AI & Imaging Synergies – Collaborate on advanced AI-driven imaging solutions to enhance diagnostic accuracy.
- Long-Term Growth Potential – Be part of a venture with strong commercial scalability and regulatory pathways.
We are especially interested in VCs with expertise in the pharmaceutical industry or contrast agent business, providing not just capital but strategic insights to accelerate commercialization.
Let’s unlock the future of medical imaging together. Get in touch today to explore collaboration and investment opportunities.